Chlorambucil
ATC L01AA02 · 10 markets · 21 records
GB 7 records · 2 strengths
AU 4 records · 3 strengths
Records without a stated strength · 1 LEUKERAN
US 2 records · 1 strengths
- 2 mgtabletLEUKERAN__no_trade__
CA 1 records · 1 strengths
- 2 mgtabletLEUKERAN
SG 1 records · 1 strengths
- 2 mgtabletLEUKERAN TABLET 2 mg (Revised Formula)
CN 1 records · 1 strengths
- 2 mgtablet留可然苯丁酸氮芥
ES 1 records · 1 strengths
- 2 mgtabletCLORAMBUCILO ASPEN
TW 1 records · 1 strengths
- 2 mgtabletLEUKERAN CHLORAMBUCIL TABLETS 2MG瘤克寧錠
HK 1 records · 1 strengths
Records without a stated strength · 1 LEUKERAN
| Strength / form / release | US | GB | CA | AU | SG | CN | ES | TW | HK |
|---|---|---|---|---|---|---|---|---|---|
| 2 mg tablet | No trade name LEUKERAN | No trade name LEUKERAN | LEUKERAN | LEUKERAN LEUKERAN chlorambucil 2mg tablet bottle | LEUKERAN TABLET 2 mg (Revised Formula) | 留可然苯丁酸氮芥 | CLORAMBUCILO ASPEN | LEUKERAN CHLORAMBUCIL TABLETS 2MG 瘤克寧錠 | |
| 5 mg tablet | LEUKERAN | LEUKERAN | |||||||
unknown | LEUKERAN | LEUKERAN |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
Also called: 於市場上銷售、瘤可宁 nickname
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.